Home / National Oncology Conference

National Oncology Conference

NOC-2019-Highlights-1408x422

 

Highlights from Orlando

The ACCC 36th National Oncology Conference, October 30-November 1 brought together hundreds of cancer care professionals and thought leaders. Over three days, attendees were encouraged to share insights, experience, and strategies for elevating the delivery of exceptional patient care and empowering the professional well-being of the entire care team.

Seven cancer programs were presented with the ACCC Innovator Award for their innovative and replicable solutions to common problems facing oncology care today.

 

Videos


WATCH: Joe Mull's No More Team Drama—LIVE at #ACCCNOC!


WATCH: The 2019 ACCC Innovator Award Winners

 


The Importance of the ACCC’s Focus on Compensation With Ali McBride as President

 

Why the Stories We Tell Matter


November 05, 2019
icon-leave-a-comment
Mary Elizabeth Williams NOC2019 (2)

ACCC 36th National Oncology Conference featured speaker author and journalist Mary Elizabeth Williams held the packed room rapt with the story of her patient experience. She was diagnosed and treated for stage II melanoma in 2010. One year later, the cancer returned. This time the melanoma was stage IV. At that time, patients with stage IV melanoma had about a five percent chance of surviving five years, Williams said.

And yet, nine years later (including two years on a clinical trial) Mary Elizabeth Williams told attendees she remains cancer-free. In a frank and down-to-earth talk titled, “Results Not Typical,” Williams shared her experiences of going through treatment as a mother with young children and one of the first patients recruited for an immuno-oncology combination drug therapy clinical trial. “I’m still considered an exceptional responder, which I love because I’m Type A,” said Williams. But she added, “I hope and pray that there will come a day very soon that what happened to me won’t be considered exceptional.”

“How did I win the cancer Powerball?” asked Williams. “I’m white. I’m college educated. I live in Manhattan, a subway ride away from one of the best cancer facilities in the world. I had no other pre-existing conditions. I’m in great health. I trained for and ran a marathon while I was in treatment. I’m a journalist trained for asking questions [as part of my profession] with a flexible job and a supportive husband. I was in a checkpoint inhibitor trial under the direction of a physician who is a Nobel Prize winner. I’m not the norm.”

Results that are not typical bring responsibility, Williams said. One responsibility that she and oncology care providers have to remember: “I don’t represent the patient population. I don’t represent the patient experience. Not even close. Not at all.”

Williams was reluctant, at first, to join a support group. But conversation with a friend led to the realization that she wasn’t the only family member who might need “not to be fine” all the time. As a member of Gilda’s Club, Williams listened to patients’ stories about how long it took to get to treatment and about spouses getting fired for taking too much time off work. “Stories about raising your kids, taking care of your parents, and trying to hang on to your job,” she said. “And if you’re interested in clinical trials, [the struggle to] just find out about them.”

While Williams is incredibly grateful for the care she received and the scientific advances and clinical trial opportunity that led to “results not typical,” she closed out her remarks with a heartfelt reminder that “the first line of defense [against cancer] is going to be communication.” 

“We’re hyped up about data, genetic testing, AI, and I’m totally down for all that,” affirmed Williams. “But I also know at the base of everything we need to be looking at the patients, the real patients.” For clinical trials to become more inclusive, the barriers to access must come down: patient distrust or wariness of clinical trials, cumbersome and lengthy enrollment processes, and lack of sufficient support on both the patient and clinical level.

“I had a great team of the best physicians in the world, and I was completely overwhelmed by my 23-page consent form. I signed that document, and I barely knew what it meant. . . so talking to patients in their own language is so important.”

In the end, Williams says communication boils down to “making sure patients and providers are on the same page. Telling the same stories, because stories are how we make decisions. Communication is about empathy and being clear. It’s not optional.”
_________________________________________________
Mary Elizabeth Williams is author of A Series of Catastrophes and Miracles: A True Story of Love, Science, and Cancer, part memoir and part a behind-the-scenes look at the new world of scientific research. 

Explore Our Photo Album

1 2 3 4 5 7 6 9 8 10 11 14 13 15 12 18 16 17 19 20 21 22

CME/CE Accreditation and Credit Designation Statements

For Physicians

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Medical and Nursing Education (IMNE) and Association of Community Cancer Centers (ACCC).

IMNE designates this live educational activity for a maximum of 8.25 AMA PRA Category 1 Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

For Nurses

IMNE is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC’s) Commission on Accreditation. This educational program provides 8.25 contact hours of continuing nursing education credit. If you have any questions regarding the CME or CE credit being offered for this meeting, please contact IMNE at info@imne.com.

Disclaimer: The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of ACCC, its members, or IMNE.

 

logo-CEAP-136x128This program is Approved by the National Association of Social Workers (Approval # 886550915-2580) for 10 continuing education contact hours.

 

Learning Objectives

After attending the ACCC 36th National Oncology Conference, participants will be better able to:

  • Evaluate recent and emerging trends and strategies designed to improve the quality of cancer care
  • Utilize relevant staff educational materials and resources in specific areas of cancer management to achieve coordinated and effective cancer care delivery and overcome common challenges that hinder operational efficiency
  • Demonstrate innovative strategies designed to promote efficiency in all aspects of cancer care, including the strategic planning process, pharmacy pre-certification and denials management, schedule optimization, and care coordination, resulting in an overall improvement of the patient experience
  • Discuss the impact of whole-person care for the management of mental, cognitive, and physical health in patients diagnosed with cancer
  • Employ technology to deliver cancer care through non-traditional avenues, including telehealth to reach at-risk populations, virtual tumor boards to facilitate prospective clinician planning, and apps to allow patients on-demand access to disease- and treatment-specific education
  • Analyze lessons learned under the first oncology-specific alternative payment model (the OCM) to help programs successfully complete the transition to value-based care
  • Summarize how to make an effective business case for adding and/or growing comprehensive cancer care services

Media Partners

logo-AJMC-290x107

logo-TargetedOncology-290x110

Supporters

This program is supported by educational grants from Abbvie, Inc., AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, Inc., Novartis, and Pfizer, Inc.

What Others are Saying

begin-quoteNetworking, idea sharing, and learning practical programs and innovations that I can bring back to my cancer center. These are the things that I value most about this conference.

—  Justin Drew, MSN, RN, NEA-BC, Director, Cancer Center, Middlesex Health Cancer Centerend-quote